In a world constantly battling against the invisible enemy, the importance of accurate and efficient nucleic acid testing cannot be overstated. And now, emerging as a game-changer in this crucial field is Tianlong – a revolutionary player that has set ablaze the production of nucleic acid testing reagents. With its cutting-edge technology and unparalleled efficiency, Tianlong is disrupting the industry, propelling people towards faster and more reliable COVID-19 detection methods. Join us on this exciting journey as we explore how Tianlong’s rise to prominence is reshaping the landscape of nucleic acid testing, revolutionizing healthcare practices worldwide.
Introduction to Tianlong
Tianlong, which was established in 1997, has become a trailblazer in the field of nucleic acid testing instruments and reagents. They offer a broad range of products and total solutions, including nucleic acid extractors (using magnetic beads), PCR thermal cyclers, real-time PCR systems, automatic nucleic acid workstations, and hundreds of compatible kits for extraction and detection. Their products have received over 70 approvals from the China NMPA and more than 120 international approvals and certifications, making them available in over 100 countries and regions globally. Tianlong’s products are widely used in clinical diagnostics, epidemic prevention and control, food safety, and scientific research. During major disease outbreaks, such as the COVID-19 pandemic, as well as other epidemics like avian influenza and Ebola, Tianlong and its products have made significant contributions to disease prevention and control.
The emergence of Tianlong is a game-changer for the production of nucleic acid testing reagents. By offering more affordable solutions to businesses and hospitals in need of reliable nucleic acid testing reagents, Tianlong has made these tests more accessible and provided a powerful tool that could potentially help many people.